NCT05223101

A Bioequivalence Study Between Telmione 80 mg and Micardis 80 mg in Healthy Adult Volunteers

A Bioequivalence Study to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety After Administration of TELMI ONE TAB. 80 mg and MICARDIS TAB. 80 mg(Telmisartan) in Healthy Adult Volunteers

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 46 (estimated)
• Sponsor: HK inno.N Corporation · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Accepted

Summary

To compare the pharmacokinetics and safety after a single dose administration of Telmione® 80 mg and Micardis® 80 mg in healthy adult volunteers

Conditions

• Hypertension

Interventions

Type	Name	Description
DRUG	Telminone 80 mg	Single administration of telmisartan 80 mg
DRUG	Drug: Micardis 80 mg	Single administration of telmisartan 80 mg

Timeline

• Start date: 2022-01-19
• Primary completion: 2022-07-01
• Completion: 2022-07-01
• First posted: 2022-02-03
• Last updated: 2022-03-02

Locations

1 site across 1 country: South Korea